Leveraging high-throughput purification to accelerate viral vector process development.

Fu, Xiaotong; Williams, Asher; Bakhshayeshi, Meisam; Pieracci, John

Leveraging high-throughput purification to accelerate viral vector process development.

Fu, Xiaotong; Williams, Asher; Bakhshayeshi, Meisam; Pieracci, John.

Afiliación

Fu X; Gene Therapy Process Development, Biogen, 225 Binney St, Cambridge, MA 02142, United States. Electronic address: Xiaotong.fu@biogen.com.
Williams A; Gene Therapy Process Development, Biogen, 225 Binney St, Cambridge, MA 02142, United States.
Bakhshayeshi M; Gene Therapy Process Development, Biogen, 225 Binney St, Cambridge, MA 02142, United States.
Pieracci J; Gene Therapy Process Development, Biogen, 225 Binney St, Cambridge, MA 02142, United States.

J Chromatogr A ; 1663: 462744, 2022 Jan 25.

Article en En | MEDLINE | ID: mdl-34971861

Asunto(s)

Dependovirus; Vectores Genéticos; Cápside; Proteínas de la Cápside; Cromatografía; Dependovirus/genética

Palabras clave

Adeno-associated virus (AAV); Gene therapy; High throughput (HTP) chromatography; Purification

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dependovirus / Vectores Genéticos Idioma: En Revista: J Chromatogr A Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google